テキサスにおける炎症性腸疾患の臨床試験
テキサス内の拠点で、炎症性腸疾患に関する16件の研究が参加者を募集しています。
テキサス内の都市
- Houston8件の研究
- Tyler5件の研究
- Round Rock5件の研究
- Garland4件の研究
- Fort Worth4件の研究
- Lewisville4件の研究
- San Antonio3件の研究
- League City3件の研究
- Lubbock3件の研究
公式研究テキスト（英語）
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research, Baytown
- DHR Health Gastroenterology - Edinburg, Edinburg
- Baylor College of Medicine, Houston
- 他3件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Cedar Park
- Xencor Investigative Site, Denton
- Xencor Investigative Site, Garland
- 他8件
被験者募集中第1/2相健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 013, Cedar Park
- Site 005, Garland
- Site 002, San Antonio
- 他2件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-024, Garland
- Site US-009, Georgetown
- Site US-030, Houston
- 他4件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07845487A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Cook Childrens Medical Center, Fort Worth
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/25更新 · NCT05923073Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345Study of DISC-0974-201 in Participants With IBD and Anemia
- One of a Kind Clinical Research Center, LLC, Kingwood
- Siena Research Network, Sugar Land
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07368972A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- GI Alliance - Cedar Park, Cedar Park
- North Texas Gastroenterology, Denton
- The University of Texas Health Science Center at Houston, Houston
- 他3件
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/22更新 · NCT06226883A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Cook Children's Medical Center, Fort Worth
被験者募集中第3相
2歳〜19歳 · 全性別 · 2026/09/22更新 · NCT04844606A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Cook Children's Medical Center, Fort Worth
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/24更新 · NCT05509777BOOM-IBD2 Pivotal Clinical Trial
- Amarillo Premier Research (Objective Health), Amarillo
- Digestive Research of Central Texas (Objective Health), Waco
被験者募集中
18歳〜85歳 · 全性別 · 2026/08/06更新 · NCT06571669HB-adMSCs for the Treatment of Crohn's Disease
- Hope Biosciences Research Foundation, Sugar Land
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/08/06更新 · NCT07077746Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/20更新 · NCT04751396A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Dallas
- Mirador Therapeutics Selected Site, Garland
- Mirador Therapeutics Selected Site, Georgetown
- 他5件
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
被験者募集中
18歳以上 · 全性別 · 2026/03/11更新 · NCT07210580Registry and Biorepository for IBD in Central Texas
- Dell Medical School, UT Austin, Austin
被験者募集中観察研究
18歳〜100歳 · 全性別 · 2021/05/18更新 · NCT04617184ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。